Workflow
南华生物:2024年报净利润-0.2亿 同比增长28.57%

Financial Performance - The company reported a basic earnings per share of -0.0600 yuan for 2024, an improvement of 33.33% compared to -0.0900 yuan in 2023 [1] - The net profit for 2024 was -0.2 billion yuan, showing a 28.57% increase from -0.28 billion yuan in 2023 [1] - The operating revenue decreased by 2.19% to 1.34 billion yuan in 2024 from 1.37 billion yuan in 2023 [1] - The return on equity was -8.03% for 2024, indicating a significant recovery from -123.33% in 2022 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 15,077.46 million shares, accounting for 48.53% of the circulating shares, with a decrease of 816.27 million shares compared to the previous period [1] - Hunan Caixin Industrial Fund Management Co., Ltd. remains the largest shareholder with 7,970.17 million shares, representing 25.65% of the total share capital [2] - New entrants among the top shareholders include Kang Suqin and Ren Hong, while Lin Liangzhong and Xu Xiao have exited the top ten list [2] Dividend Policy - The company has announced no distribution or capital increase for the current period [3]